COFLUTEQ Trademark

Trademark Overview

On Thursday, August 18, 2022, a trademark application was filed for COFLUTEQ with the United States Patent and Trademark Office. The USPTO has given the COFLUTEQ trademark a serial number of 97555183. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 8, 2024. This trademark is owned by ModernaTx, Inc.. The COFLUTEQ trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
cofluteq

General Information

Serial Number97555183
Word MarkCOFLUTEQ
Filing DateThursday, August 18, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2022

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameModernaTx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Thursday, September 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 22, 2022NEW APPLICATION ENTERED
Tuesday, August 23, 2022TEAS PETITION TO DIRECTOR RECEIVED
Monday, August 29, 2022ASSIGNED TO PETITION STAFF
Thursday, September 1, 2022PETITION TO DIRECTOR GRANTED
Friday, September 2, 2022ASSIGNED TO EXAMINER
Tuesday, September 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 2, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 2, 2023SOU EXTENSION 1 FILED
Friday, June 2, 2023SOU EXTENSION 1 GRANTED
Tuesday, June 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 13, 2023SOU EXTENSION 2 FILED
Monday, November 13, 2023SOU EXTENSION 2 GRANTED
Sunday, March 31, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, March 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, March 31, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, March 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, May 15, 2024ASSIGNED TO EXAMINER
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

cofluteq human vaccines